Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis

Although proton pump inhibitors (PPI) have a record of remarkable effectiveness and safety in the management of gastroesophageal reflux disease (GERD), several treatment challenges with PPI have emerged. Dexlansoprazole MR is the (R)-enantiomer of lansoprazole contained in a formulation that produce...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wittbrodt, Eric T, Baum, Charles, Peura, David A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2009
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108635/
https://ncbi.nlm.nih.gov/pubmed/21694835
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky